Head, Neck and Skull Base Surgery Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Head, Neck and Skull Base Surgery Program

  • 1-617-355-5798
  • International: +1-617-355-5209

Articles from John G. Meara, MD, DMD, MBA

Articles from Reza Rahbar, DMD, MD, FACS

A new target for lymphoma therapy

Frederick Alt, PhD, and his team discovered that IgH3’RR is also responsible for the over-activation of c-myc that leads to lymphoma. They believe IgH3’RR may be a new target for drugs targeting Burkitt’s lymphoma, multiple myelomas and other blood-related cancers that originate in mature B cells. Dec. 10, Nature.

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944